NCT02289807 2021-10-15
Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy
Sun Yat-sen University
Phase NA Withdrawn
Clinical Trials
6 trialsNCT03390738 2021-05-03
Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous Chemotherapy
The University of Hong Kong
Phase 2 Withdrawn
NCT04231864 2020-10-26
Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer
University of California, San Francisco
Phase 2 Withdrawn
NCT00181220 2020-05-18
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
Johns Hopkins University
Phase 1 Withdrawn
NCT00367718 2020-05-18
Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma
Johns Hopkins University
Phase 2 Withdrawn
NCT00515957 2012-04-16
DELLA
Baylor College of Medicine
Phase 1 Withdrawn